04/03/2018
Newsletters of Interest
A Few Articles You Won’t Want to Miss:
- Changes to our National Precertification List (NPL)
- Request precerts electronically — it’s fast, secure and simple
- Ordering genetic tests in the correct sequence will result in fewer denials
- Changes to commercial drug lists begin on July 1, 2018
And Much More….MARCH Mid-America Region Qtly Issue Available HERE
A Few Articles You Won’t Want to Miss:
- Blue Care Network won’t accept late claims, effective July 1
- Provider forums coming to a town near you
- Most BCN Advantage services do not require referrals
- Diagnosis and treatment of cancer
- Medical record guidelines policies require providers to maintain member records
- Medical policy updates
- Clinical editing billing tips
- Transitional care management services
- Billing Q&A
- Modifier 25
And Much More…MAY/JUNE Bi-Monthly Issue Available HERE
Current Issue Available HERE
Current Issue Available HERE (once on the site, choose NEWS on the left side)
A Few Articles You Won’t Want to Miss:
- Complete Annual Compliance Training Requirements Online
- Humana Sets Date to Close Its Secure Provider Portal
- New and Revised Pharmacy and Medical Coverage Policies Available
And Much More…Latest Issue Available HERE
A Few Articles You Won’t Want to Miss:
- Front & Center
- Denosumab (HCPCS code J0897) Requires Prior AuthorizationLink Self-Service Updates and Enhancements
- Link Self-Service Updates
- Updates to Notification/Prior Authorization Requirements for Specialty Medical Injectable Drugs
- UnitedHealthcare Commercial
- Risk Adjustment Data Validation (RADV) Audit Program
- Doing Business Better
- 2017 Quality Improvement Program Overview
And Much More…MAY Monthly Issue Available HERE
Oncology Related Articles You Won’t Want to Miss:
Medical Policy Updates
Updated:
- Molecular Oncology Testing for Cancer Diagnosis, Prognosis, and Treatment Decisions – Effective Jul. 1, 2018
Medical Benefit Drug Policy Updates
New:
- Crysvita® (Burosumab-Twza) – Effective May 1, 2018
Updated:
- Benlysta® (Belimumab) – Effective May 1, 2018
- Entyvio® (Vedolizumab) – Effective May 1, 2018
- Radicava™ (Edaravone) – Effective May 1, 2018
- Vaccines – Effective May 1, 2018
MAY Monthly Issue Available HERE